TherapeuticsMD, Inc. Other Non-Current Assets
TherapeuticsMD, Inc. (TXMD) had Other Non-Current Assets of $395.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OtherAssetsNoncurrent · last filed 2026-08-11
- 2026-06-30: Other Assets, Noncurrent $395.00K.
- 2026-03-31: Other Assets, Noncurrent $419.00K.
- 2025-12-31: Other Assets, Noncurrent $444.00K.
- 2025-09-30: Other Assets, Noncurrent $470.00K.
| Period end | Other Assets, Noncurrent | Other Assets, Noncurrent as first filed |
|---|---|---|
| 2026-06-30 | $395.00K 10-Q · filed 2026-08-11 | |
| 2026-03-31 | $419.00K 10-Q · filed 2026-05-12 | |
| 2025-12-31 | $444.00K 10-Q · filed 2026-08-11 | |
| 2025-09-30 | $470.00K 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $428.00K 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $211.00K 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $130.00K 10-K/A · filed 2026-04-01 | |
| 2024-06-30 | $58.00K 10-Q · filed 2024-08-12 | |
| 2023-12-31 | $58.00K 10-K · filed 2025-03-27 | |
| 2023-09-30 | $254.00K 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $254.00K 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $253.00K 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $253.00K 10-K · filed 2024-03-29 | |
| 2022-09-30 | $253.00K 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $254.00K 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $253.00K 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $253.00K 10-K · filed 2023-04-07 | |
| 2021-09-30 | $253.00K 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $253.00K 10-Q · filed 2021-08-04 | |
| 2021-03-31 | $253.00K 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $253.00K 10-K · filed 2022-03-23 | $51.26M 10-K · filed 2021-03-04 |
| 2020-09-30 | $52.88M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $54.45M 10-Q · filed 2020-08-07 | |
| 2020-03-31 | $54.32M 10-Q · filed 2020-05-06 | |
| 2019-12-31 | $55.06M 10-K · filed 2021-03-04 | |
| 2019-09-30 | $473.01K 10-Q · filed 2019-11-08 | |
| 2018-12-31 | $24.73M 10-K · filed 2020-02-24 | $639.30K 10-Q · filed 2019-11-08 |
| 2012-09-30 | $1.05M 10-Q · filed 2012-11-13 | |
| 2012-06-30 | $1.22M 10-Q · filed 2012-08-09 | |
| 2012-03-31 | $49.51K 10-Q · filed 2012-05-11 | |
| 2011-12-31 | $80.52K 10-Q · filed 2012-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |